Agilent Partners with Sarawak Infectious Disease Centre to Advance Research on Tropical Diseases in Malaysia

Agilent announced the signing of a Memorandum of Understanding (MOU) with the Sarawak Infectious Disease Centre (SIDC) in East Malaysia. The agreemen...

October 09, 2023 | Monday | News
Novartis Spins Off Sandoz as Independent Company

Ad hoc announcement pursuant to Art. 53 LR  Novartis executes separation of the Sandoz business to create an independent company by way of a 100% S...

October 09, 2023 | Monday | News
China's Sino Biological Opens New US-Based Center for Bioprocessing

Headquartered in Beijing, China, Sino Biological is the world’s leading provider of mammalian cell-based recombinant proteins, antibodies, and relate...

October 09, 2023 | Monday | News
Unearthing the Oasis of Discovery: The Rising Tide of Life Sciences in the Middle East

Historical Perspective Traditionally, the Middle East's economy has been heavily reliant on its vast reserves of oil and natural gas. However, the region'...

October 06, 2023 | Friday | Analysis
Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million

“Our ongoing partnership with Bayer leverages the full suite of our Twist Biopharma Solutions offering of antibody discovery services to identify the...

October 06, 2023 | Friday | News
Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools

Activates Standard BioTools’ strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of mu...

October 05, 2023 | Thursday | News
Medidata and the National Cancer Institute Extend 15-Year Partnership for an Additional Five Years

-Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry,  announced an extension ...

October 05, 2023 | Thursday | News
Danaher Corporation Completes Separation of Veralto Corporation

"Today marks an exciting milestone for Danaher. The successful spin-off of Veralto as an independent company creates exceptional opportunities for both Dan...

October 02, 2023 | Monday | News
Sartorius Forms Partnership with SPARTA Biodiscovery on Novel Nanoparticle Analysis Platform

SPARTA technology to accelerate the development, manufacture and quality control of nanoparticles used for gene therapies, vaccines, and cancer drugs The ...

September 29, 2023 | Friday | News
Revvity Expands Access to Base Editing Technology With Aim to Accelerate Discovery to Cure

Launch of Pin-pointTM base editing reagents improves access to new-generation editing technology Access to the Pin-point system now bridges discovery, p...

September 27, 2023 | Wednesday | News
European Commission Approves ORSERDU® for ER+ Breast Cancer with ESR1 Mutation

Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more tha...

September 14, 2023 | Thursday | News
10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced  that the European Unified Patent Court ("UPC") issued a...

September 20, 2023 | Wednesday | News
LifeSci Partners Expands Presence in Asia Pacific with Appointment of Jeff Seo

“LifeSci Partners is the leading provider of healthcare advisory services, with a strong presence in the U.S., Europe and Israel. We now have a great...

September 13, 2023 | Wednesday | News
Herophilus Announces Strategic Transaction with Genentech for Next-Generation Drug Discovery Platform

“Since our founding in 2017, Herophilus’s vision has been to leverage the parallel revolutions in human complex in vitro brain models, scaled l...

September 12, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close